Dry AMD Treatment

Request a Callback

What is Valeda Light Therapy?

Valeda light therapy is a treatment for Dry AMD. It uses Photobiomodulation (PBM), whereby light is applied to tissue in three wavelengths to stimulate cellar function. This treatment aims to reduce the progression of macular degeneration damage and thereby reduce the risk of visual loss.

At Optegra, we offer Dry AMD treatment at our Central London and Manchester Eye Hospitals.

What is Dry Age-Related Macular Degeneration (AMD)?

Dry Age-Related Macular Degeneration (AMD) is a common eye condition associated with ageing, characterised by the deterioration of the macula – a part of the retina responsible for central vision. In this form of AMD, the cells in the macula gradually break down, leading to a progressive loss of central vision over time. In fact, Dry AMD is the leading cause of central vision loss in people aged over 50 impacting over 700,000 people in the UK.

How Dry AMD Gradually Leads to Deteriorating Vision

Patients suffering from AMD tend to notice the following:

Gradual Progressive Loss of Vision: As AMD advances, the clarity of your central focus may diminish, resulting in blurred, distorted, severe sight impairment . This deterioration significantly affects activities like driving, recognising faces, reading, watching TV, and various aspects of daily life.

Difficulty Reading and Watching TV: The ability to discern textures and contrasts diminishes, making it challenging to navigate uneven walkways and stairs, thereby increasing the risk of falls.

Driving Limitations: Deterioration in central vision, like detecting and seeing details, reading signs and recognising – all essential tasks for safe driving – can impact your ability to drive with AMD.

Impaired Depth Perception: Difficulty in accurately judging distances poses a risk of accidents and falls.

Sensitivity to Changing Light Levels: Struggling to adapt to varying light conditions and increased sensitivity to glare become noticeable challenges.

Increased Dependence on Brighter Light: Everyday tasks such as reading, cooking, and other activities may require higher light levels due to diminishing visual acuity.

Before the advent of Valeda Light Therapy, treatment options for Dry AMD had been severely limited, relying on early detection and preventative measures to mitigate its impact on vision.

How Does Valeda Light Therapy Work?

Valeda operates by stimulating energy production within the eye’s cells, enhancing their capability to fulfil their roles effectively. The promotion of cellular health is crucial for maintaining optimal eye health.

The therapy involves a series of nine sessions spread over three weeks, typically repeated every four months. Each session lasts about five minutes per eye. Patients sit comfortably while the Valeda Light Delivery System directs controlled light pulses to the retina. The treatment is painless, non-invasive and requires no downtime.

You can return to your normal routine immediately after Valeda light therapy.

Who is Suitable for the Valeda Light Therapy System?

Valeda is a treatment available to patients with Dry Age-Related Macular Degeneration (AMD). Individuals undergoing treatment should have received a diagnosis of Dry AMD from an eye care professional. Typically, people aged 50 and above are affected by Dry Age-Related Macular Degeneration and would be suitable for the Valeda Light Therapy System.

If you are interested in learning more about Valeda, you can book a free consultation with one of our experts. We will engage in a detailed discussion about your diagnosis and collaborate with you on a personalised treatment plan. At Optegra, we ensure you have detailed tests with all the latest retinal scanning technology and a specialist consultant review to confirm you would benefit from treatment.

Is Anyone Unsuitable For Valeda Treatment?

As a safety measure, individuals who have not had a formal diagnosis of AMD or have known light exposure reactions should refrain from receiving treatment with Valeda. Similarly, those with a history of light-activated central nervous system disorders, such as epilepsy or where light exposure triggers migraine, are advised against using Valeda.

The Valeda Treatment Process

If you wear glasses or contact lenses, you will need to remove them before the Valeda treatment.
Unlike most laser and cataract eye surgeries, no dilation of the eyes is required for the Valeda light therapy.
The treatment, guided by an expert administrator, involves a step-by-step process, typically taking less than 5 minutes. You will be comfortably seated in front of the Valeda Light Delivery System for the procedure.
Bright lights may generate an afterimage post-treatment, a phenomenon recognised as photostress, wherein cells responsible for perceiving a particular colour experience fatigue. Recovery from photostress may require a few minutes after the treatment. Although this effect may manifest immediately following the session, complete recovery typically occurs within a couple of minutes. Subsequently, you can readily engage in regular activities without any hindrance following treatment.
Treatment for both eyes is completed within a time frame of less than 10 minutes.
In a recent clinical study, patients received a maximum of three treatments per week and no more than one treatment within a 24-hour period.
If a treatment is missed, it is advised to make up the session within the 3–4-week treatment series period.

The Results of Valeda & Potential Side Effects

Valeda therapy enhances comprehensive visual function, demonstrating advancements in both eyechart scores and detailed vision. Photographic imaging reveals positive changes in eye scans, particularly in the reduction or improvement of drusen, which are protein deposits commonly observed in diseased eyes.

Clinical trials have demonstrated improved visual function with a recommended treatment protocol of 3 sessions per week for 3-4 weeks for patients with Dry AMD.

What are the Side Effects of Valeda Light Therapy?

Photobiomodulation (PBM) constitutes a low-level light therapy that facilitates enhanced cellular function. Demonstrating a positive safety profile, PBM has been employed in various diseases and disorders for decades.

Clinical trials involving Dry AMD patients have indicated the safety of light therapy, with Valeda specifically engineered to ensure eye safety. Notably, previous studies involving the Valeda treatment have reported no treatment-related side effects, underscoring its safety and efficacy.

The Cost of Our Dry AMD Package

At Optegra, you will be guaranteed expert care throughout your consultation and treatment process. Our Dry AMD package includes your consultation and treatment, so the price you see is the price you’ll pay, with no hidden extra costs. The cost is the same whether it is for one or both eyes but is not available using private medical insurance.